391 related articles for article (PubMed ID: 23910390)
1. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
Pearce JW; Giuliano EA; Moore CP
Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
5. Identification of bacteria and fungi sampled from the conjunctival surface of normal horses in South-East Queensland, Australia.
Hampson ECGM; Gibson JS; Barot M; Shapter FM; Greer RM
Vet Ophthalmol; 2019 May; 22(3):265-275. PubMed ID: 29963751
[TBL] [Abstract][Full Text] [Related]
6. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
Gehrt A; Peter J; Pizzo PA; Walsh TJ
J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
8. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
Espinel-Ingroff A; Johnson E; Hockey H; Troke P
J Antimicrob Chemother; 2008 Mar; 61(3):616-20. PubMed ID: 18222957
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006).
Ledbetter EC; Patten VH; Scarlett JM; Vermeylen FM
J Am Vet Med Assoc; 2007 Oct; 231(7):1086-91. PubMed ID: 17916036
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
[TBL] [Abstract][Full Text] [Related]
11. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
12. Fungal infection of cystic fibrosis patients - single center experience.
Garczewska B; Jarzynka S; Kuś J; Skorupa W; Augustynowicz-Kopeć E
Pneumonol Alergol Pol; 2016; 84(3):151-9. PubMed ID: 27238177
[TBL] [Abstract][Full Text] [Related]
13. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.
Martinez PS; Whitley RD; Plummer CE; Richardson RL; Hamor RE; Wellehan JFX
Vet Ophthalmol; 2022 Sep; 25(5):376-384. PubMed ID: 35684950
[TBL] [Abstract][Full Text] [Related]
15. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
[TBL] [Abstract][Full Text] [Related]
16. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
[TBL] [Abstract][Full Text] [Related]
17. In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
Drago M; Scaltrito MM; Cariani L; Morace G
J Chemother; 2004 Oct; 16(5):474-8. PubMed ID: 15565915
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
[TBL] [Abstract][Full Text] [Related]
19. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Wildfeuer A; Seidl HP; Paule I; Haberreiter A
Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
